Clinical trial
Stem Cell Transplantation for Hurler
NCT00176917 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00176917 |
|---|---|
| Title | Stem Cell Transplantation for Hurler |
| Official title | Hematopoietic Stem Cell Transplantation for Hurler Syndrome, Maroteaux Lamy Syndrome (MPS VI), and Alpha Mannosidase Deficiency (Mannosidosis) |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Mannosidosis, Mucolipidosis Type II (I-cell Disease) |
| Intervention type | Drug, Procedure |
| Interventions | Stem Cell Transplant, Busulfan, Cyclophosphamide, ATG |
| Enrollment | 41 |
| Start date | May 1, 1999 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2010 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: